Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

AHCL/ SE/ 22/2026-27 August 5, 2026 The National Stock Exchange of India BSE Limited Limited Department of Corporate Services “Exchange Plaza”, C-1, Block G 1st Floor, Bandra-Kurla Complex, Bandra (E) P.J. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 ISIN: INE098F01031 Symbol : AMRUTANJAN Scrip Code: 590006 Dear Sir/ Madam, Sub: Intimation under Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Pursuant to the above mentioned regulation of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 , we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday, 11th August, 2026 at Hyderabad to consider and approve, inter- alia, the Unaudited Financial Results along with the Limited Review Report by the Statutory Auditors for the quarter ended June 30, 2026. It may also be noted that as already informed vide our letter dated 24th June 2026, the Trading Window for dealing in equity shares of the Company is closed effective from 1st July, 2026 and will remain closed till 13th August 2026 pursuant to SEBI (PIT) Regulations, 2015 and in terms of Code of Conduct to regulate, monitor and report trading in securities of the Company. Request to take the above on record and acknowledge. Thanking You, Yours faithfully For Amrutanjan Health Care Limited (Gagan Preet Singh) General Manager - Legal Company Secretary & Compliance Officer Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail : customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 CIN Tel :+91-44 - 2499 4465 - L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585